Federal Register / Vol. 66, No. 123 / Tuesday, June 26, 2001 / Notices 33965

approximately 5 p.m. two business days

before the meeting for a recorded

announcement of bank and bank

holding company applications

scheduled for the meeting; or you may

contact the Board’s Web site at http://

www.federalreserve.gov for an electronic

announcement that not only lists

applications, but also indicates

procedural and other information about

the meeting.

Dated: June 22, 2001.

Robert deV. Frierson,

Associate Secretary of the Board.

[FR Doc. 01–16089 Filed 6–22–01; 11:08 am]

BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Office of the Secretary

Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Correction.

SUMMARY: A notice beginning on page

27974 in the issue of May 21, 2001,

entitled ‘‘Findings of Scientific

Misconduct’’ is hereby reprinted in its

entirety to correctly represent the

position of Dr. Saleh with respect to the

Voluntary Exclusion Agreement that

was omitted in the original printing.

Ayman Saleh, Ph.D., University of

Pittsburgh: Based on the report of an

inquiry conducted by the University of

Pittsburgh and additional analysis

conducted by ORI in its oversight

review, the U.S. Public Health Service

(PHS) found that Dr. Saleh, former

postdoctoral research associate, School

of Medicine, University of Pittsburgh,

engaged in scientific misconduct in

research supported by the National

Institutes of Health.

PHS finds that Dr. Saleh falsified:

(A) Data for a manuscript which

purported to show Western blots of

rabbit Bcl–2 and tubulin; the blots were

actually obtained from different

experiments by another researcher using

antibody against Hsp70 and against Bag1, respectively;

(B) The label on a Western blot for

Bcl-2 that he presented to the inquiry

committee as evidence that he had

conducted the experiment at issue; the

blot was actually from a different

experiment by a coworker;

(C) Data for a laboratory figure

purported to represent a rabbit PARP

cleavage blot; the data was from another

experiment, and the antibody to PARP

was not available to Dr. Saleh at that

time;

(D) Western blot data on pcasp–9 and

p37/p35 for a manuscript on Hsp27; the

data represented experiments that could

not be performed because the cell lines

were unavailable at the time; and

(E) Figure 2b, the panel that shows a

Western blot of Casp–9(WT) in a

publication by Srinivasa M. Srinivasula,

Ramesh Hegde, Ayman Saleh, Pinaki

Datta, Eric Shiozaki, Jijie Chais, RyungAh Lee, Paul D. Robbins, Theresa

Fernandes-Alnemri, Yigong Shi, and

Emad S. Alnemri. ‘‘A conserved XIAPinteraction motif in caspase–9 and

Smac/DIABLO regulates caspase activity

and apoptosis.’’ Nature 410(6824):112–

116, 2001. The Figure 2b data were

actually taken from a Western blot of

Bcl–XL data, in which Dr. Saleh

transposed the lanes.

The experiments examined the

regulation of programmed cell death

(apoptosis), a process that is important

to a better understanding of cancer.

Figure 2b in the Nature paper

represented a control experiment that

confirmed the association of an X-linked

gene to a particular type of apoptosis.

While neither accepting nor admitting

to the findings of scientific misconduct,

Dr. Saleh has entered into a Voluntary

Exclusion Agreement with PHS in

which he has voluntarily agreed for a

period of three (3) years, beginning on

May 3, 2001:

(1) To exclude himself from any

contracting or subcontracting with any

agency of the United States Government

and from eligibility for, or involvement

in, nonprocurement transactions (e.g.,

grants and cooperative agreements) of

the United States Government as

defined in 45 CFR Part 76 (Debarment

Regulations);

(2) To exclude himself from serving in

any advisory capacity to PHS, including

but not limited to service on any PHS

advisory committee, board, and/or peer

review committee.

FOR FURTHER INFORMATION CONTACT:

Director, Division of Investigative

Oversight, Office of Research Integrity,

5515 Security Lane, Suite 700,

Rockville, MD 20852, (301) 443–5330.

Chris Pascal,

Director, Office of Research Integrity.

[FR Doc. 01–15913 Filed 6–25–01; 8:45 am]

BILLING CODE 4150–31–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration on Aging

Public Information Collection

Requirement Submitted to the Office of

Management and Budget for Clearance

AGENCY: Administration on Aging, HHS.

The Administration on Aging (AoA),

Department of Health and Human

Services, has submitted the following

proposal for the collection of

information in compliance with the

Paperwork Reduction Act (PRA; Pub. L.

96–511): State Annual Long-Term Care

Ombudsman Report and Instructions.

Type of Request: Extension of a

currently approved collection.

Use: Extension of reporting format for

use by states in reporting on activities

of their Long-Term Care Ombudsman

Programs, as required under section 712

of the Older Americans Act, as

amended.

Frequency: Annually.

Respondents: State Agencies on

Aging.

Estimated Number of Responses: 52.

Total Estimated Burden Hours: 7,235.

Additional Information or Comments:

The Administration on Aging has

submitted to the Office of Management

and Budget, for approval, an extension,

with no revisions, of a reporting form

and instructions for the State Annual

Long-Term-Care Ombudsman Report,

pursuant to requirements in Section

712(b) and (h) of the Older Americans

Act. AoA published in the March 13,

2001 Federal Register a notice that it

planned to request the extension and

inviting comments; no comments were

received. The form is currently being

evaluated for possible revision to reflect

additional programmatic reporting

needs. However, this should not affect

the PRA clearance process. Written

comments and recommendations for the

proposed information collection should

be sent within 30 days of the

publication of this notice directly to the

following address: Office of Regulatory

Affairs, Atten: Allison Herron Eydt,

OMB Desk Officer, Room 10325,

Washington, DC 20201.

Dated: June 15, 2001.

Norman L. Thompson,

Acting Principal Deputy Assistant Secretary

for Aging.

[FR Doc. 01–15919 Filed 6–25–01; 8:45 am]

BILLING CODE 4154–01–P